These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis]. Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901 [No Abstract] [Full Text] [Related]
4. Ranolazine-induced myopathy in a patient on chronic statin therapy. Correa D; Landau M J Clin Neuromuscul Dis; 2013 Mar; 14(3):114-6. PubMed ID: 23492463 [TBL] [Abstract][Full Text] [Related]
5. Myopathy after switching from brand to generic atorvastatin. Awoniyi O; Gosmanov AR J Am Geriatr Soc; 2013 Dec; 61(12):2254-2255. PubMed ID: 24329838 [No Abstract] [Full Text] [Related]
6. Statin-associated myotoxicity in an incarcerated Indigenous youth - the perfect storm. Haysom L; Samaras K; Stapylton C; Wines J Med J Aust; 2015 Apr; 202(7):381-2. PubMed ID: 25877122 [No Abstract] [Full Text] [Related]
7. [Atorvastatin . A new generation of hypolipemic agents?]. Azanza JR; Sádaba B; Quetglas EG Rev Med Univ Navarra; 1998; 42(1):51-5. PubMed ID: 10420957 [No Abstract] [Full Text] [Related]
8. Atorvastatin for stroke prevention. Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287 [No Abstract] [Full Text] [Related]
9. Safety of statin therapy in patients with mitochondrial diseases. Hannah-Shmouni F; Al-Sarraf A; Frohlich J; Mezei MM; Sirrs S; Mattman A J Clin Lipidol; 2013; 7(2):182. PubMed ID: 23415441 [No Abstract] [Full Text] [Related]
10. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort. Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270 [No Abstract] [Full Text] [Related]
11. [Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine]. García-Estévez DA; San Millán B; Navarro C; Sogo T Med Clin (Barc); 2013 Jun; 140(12):565-7. PubMed ID: 23337446 [No Abstract] [Full Text] [Related]
12. Atorvastatin and amlodipine: the successful duet that led to Caduet. Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825 [No Abstract] [Full Text] [Related]
13. Statins: much more than just a lipid-lowering therapy. Raja SG; Dreyfus GD Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561 [No Abstract] [Full Text] [Related]
14. Statin-induced, immune-mediated necrotising myopathy triggered by malignancy successfully treated with immunosuppression. Abouelazm A; Philops K; Amine A; Golam Y Clin Med (Lond); 2024 May; 24(3):100217. PubMed ID: 38710328 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia]. Liguori E; Sarcinella R Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861 [No Abstract] [Full Text] [Related]
16. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
18. Statin, the black box. Hatem S; Boccara F Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149 [No Abstract] [Full Text] [Related]
19. Not a graves' situation. Ruchala M; Szczepanek E; Puszczewicz M; Sosnowski P; Sowinski J Am J Med; 2011 Mar; 124(3):210-4. PubMed ID: 21396501 [No Abstract] [Full Text] [Related]
20. Multiorgan failure induced by atorvastatin. Sreenarasimhaiah J; Shiels P; Lisker-Melman M Am J Med; 2002 Sep; 113(4):348-9. PubMed ID: 12361829 [No Abstract] [Full Text] [Related] [Next] [New Search]